Sign In

Sam Fazeli

Director of Research, Global Industries, Bloomberg Intelligence; Non Executive Director at Arecor Limited

Sam Fazeli is the Director of Research for Global Industries at Bloomberg Intelligence, where he also serves as a Senior Pharmaceuticals Analyst.12 He has over 20 years of experience in equity research, focusing on European pharmaceuticals and biotechnology.1 Before joining Bloomberg in 2010, Fazeli worked as a pharmaceutical analyst and head of European research at Piper Jaffray, Ltd., and held positions at Nomura International and HSBC.1

Dr. Fazeli began his career as a research scientist for seven years before transitioning to investment banking. He has been recognized as a top analyst by both the U.K. and Pan-European Extel surveys.1 He holds a Bachelor of Science from Cardiff University and a Ph.D. in pharmacology from the University of London.1 Based in London, Fazeli is also active on LinkedIn with over 500 connections.3

Highlights

Sep 6 · linkedin

Tolebrutinib; China Biotech; Viking Blockbuster: BI Drug Call by Bloomberg Intelligence on #SoundCloud

Aug 14 · linkedin

Had a great discussion with Harren Jhoti of Astex on how AI can be used in drug discovery and development. Was a real pleasure talking with Harren who has been involved in the discovery of several important marketed drugs.

Related Questions

What are some of Sam Fazeli's most notable research reports at Bloomberg?
How has Sam Fazeli's career evolved over the past 20 years?
What specific companies has Sam Fazeli analyzed in the pharmaceutical sector?
How does Sam Fazeli's background in pharmacology influence his research?
What are the key trends Sam Fazeli has identified in European pharmaceuticals?
Sam Fazeli
Sam Fazeli, photo 1
Sam Fazeli, photo 2
Add to my network

Location

London, England, United Kingdom